BridgeMD
Tests treatment safety and results for Breast Cancer
Official title Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal
ClinicalTrials.gov ID: NCT06977360
What this study is testing
- What it's testing
- The overall aim of the study is to evaluate the feasibility, acceptability and preliminary effects of the next iteration of iCareBreast+, an innovative breast care e-support intervention programme, by refining existing contents and building new contents based on comprehensive assessment of breast cancer women's needs and preferences among breast cancer patients undergoing chemotherapy. The specific objectives of this study are: 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 100, women only
You may be able to join if
- Women who:
- are the age of 21 years old and above at the point of recruitment;
- are diagnosed with stage 1-3 breast cancer;
- will undergo chemotherapy first time (initiating or up to #4 cycles of chemo is acceptable);
- can speak, read and write in English or Mandarin; and
You likely can't join if
- Those who :
- are with a history of or concurrent other cancer types;
- have been suffering from psychiatric illness (e.g., schizophrenia), anxiety disorder or other mood disorder or impaired cognitive function;
- have alcohol or substance abuse within the previous year;
- are undergoing concurrent psychosocial interventions; and
- have been in the bereavement period in the last 6 months
See the full eligibility criteria
- Women who:
- are the age of 21 years old and above at the point of recruitment;
- are diagnosed with stage 1-3 breast cancer;
- will undergo chemotherapy first time (initiating or up to #4 cycles of chemo is acceptable);
- can speak, read and write in English or Mandarin; and
- has access to and able to use smart phone.
- Those who :
- are with a history of or concurrent other cancer types;
- have been suffering from psychiatric illness (e.g., schizophrenia), anxiety disorder or other mood disorder or impaired cognitive function;
- have alcohol or substance abuse within the previous year;
- are undergoing concurrent psychosocial interventions; and
- have been in the bereavement period in the last 6 months
- are in their pregnancy.
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 21 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.